Fluoroalkane modified cationic polymers for personalized mRNA cancer vaccines

Delivery carriers are a critical component in the development of mRNA vaccines. Here, we describe the synthesis of a cationic polymer as a carrier for mRNA cancer vaccine delivery. In vivo results show that this polymer-based mRNA vaccine significantly delays tumor growth after vaccination of mice.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743697/

 



Fluoroalkane modified cationic polymers for personalized mRNA cancer vaccine-CEJ 2023 Jan

Download

← Return to Resources

Related Content

Expanded Role of PDX Models in Anticancer Drug Development Patient-derived xenograft (PDX) models are established by implanting surgically resected patient...

VIEW RESOURCE

Cyclin-dependent kinases (CDKs) and their cyclin regulatory subunits form complexes that are essential for driving abnormal growth processes in cancer...

VIEW RESOURCE
← View all Oncology Resources
× peptide, amino acid

Contact An Expert Today!